This innovative sensor platform’s ability to accurately detect lower levels of CEA in serum samples positions it as a cutting-edge instrument for early-stage cancer diagnostics, offering the potential for timely and effective cancer treatment. This evidence concerns the gene CEACAM5 and cancer.